Yahoo Finance New Strong Buy Stocks for December 13th
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:
NMI Holdings, Inc. (NMIH): This company that provides private mortgage guaranty insurance services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
NMI Holdings Inc Price and Consensus
NMI Holdings Inc price-consensus-chart | NMI Holdings Inc Quote
America's Car-Mart, Inc. (CRMT): This company that operates as an automotive retailer has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.5% over the last 60 days.
America's Car-Mart, Inc. Price and Consensus
America's Car-Mart, Inc. price-consensus-chart | America's Car-Mart, Inc. Quote
comScore, Inc. (SCOR): This company that operates as an information and analytics company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 11.6% over the last 60 days.
comScore, Inc. Price and Consensus
comScore, Inc. price-consensus-chart | comScore, Inc. Quote
Emmaus Life Sciences, Inc. (EMMA): This company that engages in the discovery, development, and commercialization of treatments and therapies has witnessed the Zacks Consensus Estimate for its current year earnings increasing 83.3% over the last 60 days.
Emmaus Life Sciences, Inc. Price and Consensus
Emmaus Life Sciences, Inc. price-consensus-chart | Emmaus Life Sciences, Inc. Quote
InterXion Holding N.V. (INXN): This company that provides carrier and cloud-neutral colocation data center services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 23.6% over the last 60 days.
InterXion Holding N.V. Price and Consensus
InterXion Holding N.V. price-consensus-chart | InterXion Holding N.V. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
comScore, Inc. (SCOR) : Free Stock Analysis Report
NMI Holdings Inc (NMIH) : Free Stock Analysis Report
InterXion Holding N.V. (INXN) : Free Stock Analysis Report
Emmaus Life Sciences, Inc. (EMMA) : Free Stock Analysis Report
America's Car-Mart, Inc. (CRMT) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
